175 related articles for article (PubMed ID: 9659297)
1. Mutation and expression analysis of the cyclin-dependent kinase inhibitor gene p27/Kip1 in pituitary tumors.
Takeuchi S; Koeffler HP; Hinton DR; Miyoshi I; Melmed S; Shimon I
J Endocrinol; 1998 May; 157(2):337-41. PubMed ID: 9659297
[TBL] [Abstract][Full Text] [Related]
2. Molecular analysis of the cyclin-dependent kinase inhibitor gene p27/Kip1 in human malignancies.
Kawamata N; Morosetti R; Miller CW; Park D; Spirin KS; Nakamaki T; Takeuchi S; Hatta Y; Simpson J; Wilcyznski S
Cancer Res; 1995 Jun; 55(11):2266-9. PubMed ID: 7757974
[TBL] [Abstract][Full Text] [Related]
3. Mutation and expression analysis of the p27/kip1 gene in corticotrophin-secreting tumours.
Dahia PL; Aguiar RC; Honegger J; Fahlbush R; Jordan S; Lowe DG; Lu X; Clayton RN; Besser GM; Grossman AB
Oncogene; 1998 Jan; 16(1):69-76. PubMed ID: 9467944
[TBL] [Abstract][Full Text] [Related]
4. p27/Kip1 mutation found in breast cancer.
Spirin KS; Simpson JF; Takeuchi S; Kawamata N; Miller CW; Koeffler HP
Cancer Res; 1996 May; 56(10):2400-4. PubMed ID: 8625318
[TBL] [Abstract][Full Text] [Related]
5. Mice lacking p27(Kip1) display increased body size, multiple organ hyperplasia, retinal dysplasia, and pituitary tumors.
Nakayama K; Ishida N; Shirane M; Inomata A; Inoue T; Shishido N; Horii I; Loh DY; Nakayama K
Cell; 1996 May; 85(5):707-20. PubMed ID: 8646779
[TBL] [Abstract][Full Text] [Related]
6. Persistent and heterogenous expression of the cyclin-dependent kinase inhibitor, p27KIP1, in rat hearts during development.
Koh KN; Kang MJ; Frith-Terhune A; Park SK; Kim I; Lee CO; Koh GY
J Mol Cell Cardiol; 1998 Mar; 30(3):463-74. PubMed ID: 9515024
[TBL] [Abstract][Full Text] [Related]
7. Loss of the cyclin-dependent kinase inhibitor p27(Kip1) protein in human prostate cancer correlates with tumor grade.
Guo Y; Sklar GN; Borkowski A; Kyprianou N
Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2269-74. PubMed ID: 9815624
[TBL] [Abstract][Full Text] [Related]
8. The concurrent expression of p27(kip1) and cyclin D1 in epithelial ovarian tumors.
Sui L; Tokuda M; Ohno M; Hatase O; Hando T
Gynecol Oncol; 1999 May; 73(2):202-9. PubMed ID: 10329035
[TBL] [Abstract][Full Text] [Related]
9. Multiple functions of p27(Kip1) and its alterations in tumor cells: a review.
Sgambato A; Cittadini A; Faraglia B; Weinstein IB
J Cell Physiol; 2000 Apr; 183(1):18-27. PubMed ID: 10699962
[TBL] [Abstract][Full Text] [Related]
10. Reduced expression of the CDK inhibitor p27(KIP1) in rat two-stage bladder carcinogenesis and its association with expression profiles of p21(WAF1/Cip1) and p53.
Lee CC; Ichihara T; Yamamoto S; Wanibuchi H; Sugimura K; Wada S; Kishimoto T; Fukushima S
Carcinogenesis; 1999 Sep; 20(9):1697-708. PubMed ID: 10469613
[TBL] [Abstract][Full Text] [Related]
11. Loss of cell cycle regulators p27(Kip1) and cyclin E in transitional cell carcinoma of the bladder correlates with tumor grade and patient survival.
Del Pizzo JJ; Borkowski A; Jacobs SC; Kyprianou N
Am J Pathol; 1999 Oct; 155(4):1129-36. PubMed ID: 10514396
[TBL] [Abstract][Full Text] [Related]
12. Low levels of cyclin D and nonfunctional Rb protein affect cdk6 association with cyclin-dependent kinase inhibitor p27(Kip1).
Kwon TK; Park JW
Biochem Biophys Res Commun; 2001 Jun; 284(1):106-11. PubMed ID: 11374878
[TBL] [Abstract][Full Text] [Related]
13. p27 Expression, a cyclin dependent kinase inhibitor in breast carcinoma.
Barbareschi M
Adv Clin Path; 1999 Oct; 3(4):119-27. PubMed ID: 10936889
[TBL] [Abstract][Full Text] [Related]
14. Mutational analysis of the p27(kip1) gene in hepatocellular carcinoma.
Chen TC; Ng KF; Lien JM; Jeng LB; Chen MF; Hsieh LL
Cancer Lett; 2000 May; 153(1-2):169-73. PubMed ID: 10779646
[TBL] [Abstract][Full Text] [Related]
15. p27 and Rb are on overlapping pathways suppressing tumorigenesis in mice.
Park MS; Rosai J; Nguyen HT; Capodieci P; Cordon-Cardo C; Koff A
Proc Natl Acad Sci U S A; 1999 May; 96(11):6382-7. PubMed ID: 10339596
[TBL] [Abstract][Full Text] [Related]
16. High level expression of p27(kip1) and cyclin D1 in some human breast cancer cells: inverse correlation between the expression of p27(kip1) and degree of malignancy in human breast and colorectal cancers.
Fredersdorf S; Burns J; Milne AM; Packham G; Fallis L; Gillett CE; Royds JA; Peston D; Hall PA; Hanby AM; Barnes DM; Shousha S; O'Hare MJ; Lu X
Proc Natl Acad Sci U S A; 1997 Jun; 94(12):6380-5. PubMed ID: 9177226
[TBL] [Abstract][Full Text] [Related]
17. Reduced expression levels of the cell-cycle inhibitor p27Kip1 in human pituitary adenomas.
Bamberger CM; Fehn M; Bamberger AM; Lüdecke DK; Beil FU; Saeger W; Schulte HM
Eur J Endocrinol; 1999 Mar; 140(3):250-5. PubMed ID: 10216521
[TBL] [Abstract][Full Text] [Related]
18. p27/kip1 expression in human astrocytic gliomas.
Piva R; Cavalla P; Bortolotto S; Cordera S; Richiardi P; Schiffer D
Neurosci Lett; 1997 Oct; 234(2-3):127-30. PubMed ID: 9364514
[TBL] [Abstract][Full Text] [Related]
19. CDK inhibitors p18(INK4c) and p27(Kip1) mediate two separate pathways to collaboratively suppress pituitary tumorigenesis.
Franklin DS; Godfrey VL; Lee H; Kovalev GI; Schoonhoven R; Chen-Kiang S; Su L; Xiong Y
Genes Dev; 1998 Sep; 12(18):2899-911. PubMed ID: 9744866
[TBL] [Abstract][Full Text] [Related]
20. Cyclin-dependent kinase inhibitor P27(KIP1) is expressed preferentially in early stages of urothelial carcinoma.
Franke KH; Miklosi M; Goebell P; Clasen S; Steinhoff C; Anastasiadis AG; Gerharz C; Schulz WA
Urology; 2000 Oct; 56(4):689-95. PubMed ID: 11018640
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
